Amylin, Alkermes up on exenatide LAR data

On Tuesday, AMLN rose $6.07 (28%) to $28 on 32.2 million shares and ALKS added $1.84 (12%) to $17.67 on 7.5 million shares. On Monday after market close, AMLN, ALKS and Eli Lilly (LLY) said preliminar...